↓ Skip to main content

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons

Overview of attention for article published in BMC Infectious Diseases, March 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
19 X users

Citations

dimensions_citation
89 Dimensions

Readers on

mendeley
109 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
Published in
BMC Infectious Diseases, March 2010
DOI 10.1186/1471-2334-10-71
Pubmed ID
Authors

Lisa A Jackson, Manjusha J Gaglani, Harry L Keyserling, John Balser, Nancy Bouveret, Louis Fries, John J Treanor

Abstract

Seasonal influenza imposes a substantial personal morbidity and societal cost burden. Vaccination is the major strategy for influenza prevention; however, because antigenically drifted influenza A and B viruses circulate annually, influenza vaccines must be updated to provide protection against the predicted prevalent strains for the next influenza season. The aim of this study was to assess the efficacy, safety, reactogenicity, and immunogenicity of a trivalent inactivated split virion influenza vaccine (TIV) in healthy adults over two influenza seasons in the US.

X Demographics

X Demographics

The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
Unknown 107 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 27 25%
Student > Ph. D. Student 18 17%
Student > Master 17 16%
Student > Bachelor 13 12%
Student > Postgraduate 8 7%
Other 9 8%
Unknown 17 16%
Readers by discipline Count As %
Medicine and Dentistry 39 36%
Agricultural and Biological Sciences 15 14%
Nursing and Health Professions 6 6%
Psychology 5 5%
Biochemistry, Genetics and Molecular Biology 4 4%
Other 15 14%
Unknown 25 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2023.
All research outputs
#1,559,717
of 25,506,250 outputs
Outputs from BMC Infectious Diseases
#388
of 8,641 outputs
Outputs of similar age
#5,573
of 110,435 outputs
Outputs of similar age from BMC Infectious Diseases
#4
of 42 outputs
Altmetric has tracked 25,506,250 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,641 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,435 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.